John Hancock Classic Value Fund (JCVSX)
| Fund Assets | 511.89M |
| Expense Ratio | 1.25% |
| Min. Investment | $250,000 |
| Turnover | 13.00% |
| Dividend (ttm) | 6.98 |
| Dividend Yield | 32.94% |
| Dividend Growth | -43.40% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 19, 2025 |
| Previous Close | 21.18 |
| YTD Return | 9.51% |
| 1-Year Return | 12.82% |
| 5-Year Return | 31.38% |
| 52-Week Low | 17.70 |
| 52-Week High | 26.58 |
| Beta (5Y) | 1.55 |
| Holdings | 35 |
| Inception Date | Mar 1, 2012 |
About JCVSX
John Hancock Classic Value Fund Class R2 is a mutual fund designed primarily to deliver long-term capital growth by investing at least 80% of its net assets in domestic equity securities. The fund follows a value-oriented strategy, targeting companies that are considered undervalued relative to their intrinsic worth. This focus makes the fund particularly relevant for investors seeking exposure to U.S. stocks with strong fundamentals trading at attractive valuations. John Hancock Classic Value Fund Class R2 spreads its investments across a diverse range of sectors, aiming to provide broad market representation within its value discipline. The fund offers Class R2 shares, which are commonly utilized in retirement plans and feature competitive expense structures along with specific service fee arrangements. Its role in the financial market is to serve as a portfolio component that can potentially offer stability and growth by emphasizing value stocks, thus appealing to investors looking to diversify equity holdings through a disciplined, research-driven approach.
Performance
JCVSX had a total return of 12.82% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.65%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| VWNEX | Vanguard | Vanguard Windsor Admiral | 0.18% |
Top 10 Holdings
42.10% of assets| Name | Symbol | Weight |
|---|---|---|
| CVS Health Corporation - CVS HEALTH CORP COMMON STOCK USD.01 | CVS.US | 5.43% |
| Humana Inc. - HUMANA INC COMMON STOCK USD.1666666 | HUM.US | 5.41% |
| Baxter International Inc. - BAXTER INTERNATIONAL INC COMMON STOCK USD1.0 | BAX.US | 4.86% |
| Skyworks Solutions Inc. - SKYWORKS SOLUTIONS INC COMMON STOCK USD.25 | SWKS.US | 4.28% |
| FRESENIUS MEDICAL CARE AG ADR | FMS.US | 3.95% |
| Citigroup Inc. - CITIGROUP INC COMMON STOCK USD.01 | C.US | 3.89% |
| Magna International Inc. - MAGNA INTERNATIONAL INC COMMON STOCK | MGA.US | 3.63% |
| MetLife Inc. - METLIFE INC COMMON STOCK USD.01 | MET.US | 3.61% |
| Wells Fargo and Company - WELLS FARGO and CO COMMON STOCK USD1.666 | WFC.US | 3.58% |
| Corebridge Financial Inc. - COREBRIDGE FINANCIAL INC COMMON STOCK USD.01 | CRBG.US | 3.46% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2025 | $6.97748 | Dec 22, 2025 |
| Dec 20, 2024 | $12.32735 | Dec 23, 2024 |
| Dec 19, 2023 | $2.14443 | Dec 20, 2023 |
| Dec 19, 2022 | $5.92992 | Dec 20, 2022 |
| Dec 17, 2021 | $0.18375 | Dec 20, 2021 |
| Dec 18, 2020 | $0.36777 | Dec 21, 2020 |